Table 2.
Significant markers associated with the modified clinical severity score of the study participants with COVID-19a.
Variable | t test (or ANOVA) | Cochran–Armitage trend test | Pearson correlation analysis | Spearman correlation analysis | Kendall rank correlation analysis | ||||||||||||||||
|
t (or F) | P value | T | P value | r | P value | ρ | P value | T | P value | |||||||||||
Qualitative | |||||||||||||||||||||
|
Age | N/Ab | <.001 | N/A | N/A | 0.41 | <.001 | 0.38 | <.001 | 0.32 | <.001 | ||||||||||
|
Sex | –0.08 | <.001 | (1)c | N/A | –0.05 | <.001 | –0.03 | .01 | –0.03 | .01 | ||||||||||
|
BMI | N/A | <.001 | N/A | N/A | 0.05 (.002) | .002 | 0.04 | .007 | 0.04 | .007 | ||||||||||
|
Systolic blood pressure | 0.11 | <.001 | N/A | <.001 | 0.06 (P<.001) | <.001 | 0.05 | <.001 | 0.05 | <.001 | ||||||||||
|
Heart rate | N/A | <.001 | N/A | N/A | 0.04 | .003 | 0.03 (.03) | N/A | 0.03 | .03 | ||||||||||
|
Temperature | 0.43 | <.001 | N/A | <.001 | 0.18 | <.001 | 0.18 | <.001 | 0.18 | <.001 | ||||||||||
|
Fever | 0.39 | <.001 | N/A | <.001 | 0.19 | <.001 | 0.19 | <.001 | 0.19 | <.001 | ||||||||||
|
Sputum | 0.08 | .002 | N/A | <.001 | 0.04 | .002 | 0.04 | .006 | 0.04 | .006 | ||||||||||
|
Sore throat | –0.17 | <.001 | 1 | N/A | –0.07 | <.001 | –0.06 | <.001 | –0.06 | <.001 | ||||||||||
|
Runny nose or rhinorrhea | –0.19 | <.001 | 1 | N/A | –0.07 | <.001 | –0.07 | <.001 | –0.06 | <.001 | ||||||||||
|
Fatigue or malaise | 0.24 | <.001 | N/A | <.001 | 0.06 | <.001 | 0.05 | <.001 | 0.05 | <.001 | ||||||||||
|
Shortness of breath | 0.95 | <.001 | N/A | <.001 | 0.36 | <.001 | 0.31 | <.001 | 0.30 | <.001 | ||||||||||
|
Headache | –0.12 | <.001 | 1 | N/A | –0.05 | <.001 | –0.05 | <.001 | –0.05 | <.001 | ||||||||||
|
Altered consciousness or confusion | 1.98 | <.001 | N/A | <.001 | 0.18 | <.001 | 0.14 | <.001 | 0.14 | <.001 | ||||||||||
|
Vomiting or nausea | 0.26 | <.001 | N/A | <.001 | 0.06 | <.001 | 0.06 | <.001 | 0.06 | <.001 | ||||||||||
|
Diabetes mellitus | 0.56 | <.001 | N/A | <.001 | 0.21 | <.001 | 0.19 | <.001 | 0.19 | <.001 | ||||||||||
|
Hypertension | 0.57 | <.001 | N/A | <.001 | 0.27 | <.001 | 0.25 | <.001 | 0.24 | <.001 | ||||||||||
|
Heart failure | 1.22 | <.001 | N/A | <.001 | 0.14 | <.001 | 0.13 | <.001 | 0.13 | <.001 | ||||||||||
|
Chronic cardiovascular disease | 0.6 | <.001 | N/A | <.001 | 0.12 | <.001 | 0.12 | <.001 | 0.11 | <.001 | ||||||||||
|
Asthma | 0.23 | .01 | N/A | .001 | 0.04 | .003 | 0.04 | .005 | 0.04 | <.001 | ||||||||||
|
Chronic obstructive pulmonary disease | 0.93 | <.001 | N/A | <.001 | 0.09 | <.001 | 0.08 | <.001 | 0.08 | <.001 | ||||||||||
|
Chronic kidney disease | 1.19 | <.001 | N/A | <.001 | 0.14 | <.001 | 0.12 | <.001 | 0.12 | <.001 | ||||||||||
|
Cancer | 0.43 | <.001 | N/A | <.001 | 0.08 | <.001 | 0.07 | <.001 | 0.07 | <.001 | ||||||||||
|
Chronic liver disease | 0.28 | .02 | N/A | .002 | 0.04 | .004 | 0.04 | .005 | 0.04 | .005 | ||||||||||
|
Dementia | 1.26 | <.001 | N/A | <.001 | 0.29 | <.001 | 0.29 | <.001 | 0.28 | <.001 | ||||||||||
Quantitative | |||||||||||||||||||||
|
Hemoglobin | N/A | N/A | N/A | N/A | –0.22 | <.001 | –0.19 | <.001 | –0.15 | <.001 | ||||||||||
|
Hematocrit | N/A | N/A | N/A | N/A | –0.24 | <.001 | –0.21 | <.001 | –0.17 | <.001 | ||||||||||
|
Lymphocytes | N/A | N/A | N/A | N/A | –0.38 | <.001 | –0.35 | <.001 | –0.28 | <.001 | ||||||||||
|
Platelets | N/A | N/A | N/A | N/A | –0.19 | <.001 | –0.22 | <.001 | –0.17 | <.001 | ||||||||||
|
White blood cells | N/A | N/A | N/A | N/A | 0.12 | <.001 | 0.04 | .02 | 0.03 | .02 |
aFor each test, a variable with positive coefficient represents the predictor positively associated with an increase in clinical severity.
bN/A: not applicable.
cSex: Female=1, Male=0; clinical findings or comorbidities; Yes=1, No=0.